Faculty profile

Salmaan Kanji

Back to faculty

Assistant ProfessorDepartment of MedicineUniversity of Ottawa

Salmaan Kanji

Assistant Professor

Department of Medicine

Faculty of Medicine

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
59 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

121

Publications

1,854

Citations

h-index

190

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Climate Change Environmental Sustainability Healthcare Sustainability Knowledge Synthesis Agitated Delirium Dexmedetomidine Palliative Care Phase I/Ii Clinical Trial

Latest papers

Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery.
The New England journal of medicine · 2026
Anabolic androgen therapy in critically ill adults: A systematic review and meta-analysis.
Journal of critical care · 2026
Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy.
Critical care (London, England) · 2026

All 121 publications

Latest funding

Adjunctive Methylene Blue in Septic Shock (BLUSH) - A Multicentre Pilot Feasibility Trial
CIHR · 2026 · Co-investigator
$543,150
PROVE-ICU: Anti-Xa-guided, weight-based low-molecular-weight heparin thromboprophylaxis versus fixed dosing in critically ill adults - a multicentre pilot randomized trial
CIHR · 2026 · Co-investigator
$286,876
OVATION-CEPEC: Optimal VAsopressor titraTION within the Canadian Critical Care Comparative Effectiveness Platform(e) d'Évaluation Clinique Comparée en soins Critiques (CEPEC)
CIHR · 2025 · Co-investigator
$3,021,752

All 27 grants and awards

121 publications.

Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery.

Houston BL, McIsaac DI, Breau RH, Kanji S, Greenstreet P, Andrews M, Avramescu S, Bagry HS, Balshaw R, Daya J, Duncan K, Harle CC, Jacobsohn E, Kerelska T, Pitz M, Komenda P, McIsaac S, Ramsay T, Saha T, Tinmouth A, Recio A, Szoke D, Tenenbein M, Slagerman S, Solvason D, Talarico R, Fergusson DA, Zarychanski R

The New England journal of medicine2026

DOI: 10.1056/nejmoa2515820 PMID: 42267805

Anabolic androgen therapy in critically ill adults: A systematic review and meta-analysis.

Blaskovits F, Meggison H, Haddara W, Rochwerg B, Fernando SM, Durr K, Kanji S, Christie R, Grewal A, Fairbairn J, Iyengar A, Kubelik D, Tran A

Journal of critical care2026

DOI: 10.1016/j.jcrc.2026.155687 PMID: 42526360

Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy.

Ulldemolins M, Lipman J, Liu X, Abdul-Aziz MH, Baptista JP, Bilgrami I, Bitker L, Boidin C, Brinkmann A, Cheng V, Choi G, Cole CL, De Waele JJ, Deans R, Eastwood GM, Escobar L, Frey OR, Garreau R, Goutelle S, Gresham R, Hernandez-Mitre MP, Jamal JA, Joynt GM, Kanji S, Kielstein JT, Kluge S, König C, Koulouras VP, Lassig-Smith M, Laterre PF, Lee A, Lefrant JY, Lei K, Leung P, Mat-Nor MB, Mudaliar Y, Ostermann M, Paul SK, Peake SL, Rello J, Richard JC, Richards B, Roberts DM, Roberts MS, Roehr AC, Roger C, Seoane L, Shekar K, Sinnollareddy M, Sousa E, Spring A, Starr T, Stephens D, Taccone FS, Thomas J, Turnidge J, Valkonen M, Wallis SC, Williams T, Wittebole X, Wright DFB, Zikou XT, Roberts JA, SMARRT Study Collaborators, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Groups for Infections in Critically Ill Patients (ESGCIP) and the ESCMID PK/PD of Anti-Infectives Study Group (EPASG)

Critical care (London, England)2026

DOI: 10.1186/s13054-026-06226-z PMID: 42706573

Exploring the methodological quality and risk of bias in 200 systematic reviews: A comparative study of ROBIS and AMSTAR-2 tools.

Lunny C, Jain N, Nazari T, Kosaner-Kließ M, Santos L, Goodman I, Osman AAM, Berrone S, Dadam MN, Brenna CTA, Hussein H, Dahdal G, Cespedes A D, Ferri N, Kanji S, Chi Y, Pieper D, Shea B, Parker A, Neupane D, Khan PA, Rangira D, Kolaski K, Ridley B, Berour A, Sun K, Hamidi Rad R, Ouyang Z, Reid EK, Pérez-Neri I, Barakat SO, Bargeri S, Gianola S, Castellini G, Whitelaw S, Stevens A, Kolekar SB, Wong K, Major P, Bagheri E, Tricco AC

Research synthesis methods2026

DOI: 10.1017/rsm.2025.10032 PMID: 41626887

Authors reply: "What every intensivist should know about…Methylene blue in septic shock".

Fernando SM, Soliman K, Tran A, Kanji S, Rochwerg B

Journal of critical care2026

DOI: 10.1016/j.jcrc.2026.155451 PMID: 41581357

A Multi-Stage Drop-the-Loser Design With Superiority Boundaries.

Greenstreet P, Khan M, Kanji S, Motazedian P, Seely A, Sibley S, Ramsay T

Statistics in medicine2026

DOI: 10.1002/sim.70642 PMID: 42338347

Methylene Blue Administration in Septic Shock: A Retrospective Cohort Study

Fernando SM, Rochwerg B, Soliman K, Tran A, Flynn B, Oommen T, Kanji S, Seely AJE, Fox-Robichaud AE, Wax RS

Critical Care Medicine20263 citations

DOI: 10.1097/ccm.0000000000006934

What every intensivist should know about…methylene blue in septic shock

Fernando SM, Soliman K, Tran A, Kanji S, Rochwerg B

Journal of Critical Care20263 citations

DOI: 10.1016/j.jcrc.2025.155353

Anti-Xa Levels With Venous Thromboembolism Prophylaxis in Critical Care: A Systematic Review and Meta-Analysis

Durr KM, Ehlebracht A, Rochwerg B, Fernando SM, Gillen JR, Buccholz C, McIntyre L, Carrier M, Siegal DM, Patel R

Critical Care Medicine20261 citations

DOI: 10.1097/ccm.0000000000007079

Population Pharmacokinetics of Intravenous Vitamin C in Adults with Sepsis: A Sub-study of the LOVIT Trial

Kanji S, Hernández-Mitre MP, Blain H, Adhikari NKJ, Lamontagne F, Battista M-C, Ménard J, Sprague S, Masse M-H, Roberts JA

Clinical Pharmacokinetics20261 citationsFirst author

DOI: 10.1007/s40262-026-01648-y

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Salmaan Kanji

Research

Latest papers

Latest funding

Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery.

Anabolic androgen therapy in critically ill adults: A systematic review and meta-analysis.

Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy.

Exploring the methodological quality and risk of bias in 200 systematic reviews: A comparative study of ROBIS and AMSTAR-2 tools.

Authors reply: "What every intensivist should know about&#x2026;Methylene blue in septic shock".

A Multi-Stage Drop-the-Loser Design With Superiority Boundaries.

Methylene Blue Administration in Septic Shock: A Retrospective Cohort Study

What every intensivist should know about…methylene blue in septic shock

Anti-Xa Levels With Venous Thromboembolism Prophylaxis in Critical Care: A Systematic Review and Meta-Analysis

Population Pharmacokinetics of Intravenous Vitamin C in Adults with Sepsis: A Sub-study of the LOVIT Trial

Frequent collaborators

Brian Hutton

Deborah Cook

Bram Rochwerg

Alexandre Tran

Sangeeta Mehta

Alison Fox-Robichaud

Swapnil Hiremath

Lisa Burry

Gordon Guyatt

Kednapa Thavorn

Kednapa Thavorn

Emilie Belley-Cote

David Moher

Ryan Zarychanski

James Downar

Dean Fergusson

Franco Momoli

Sheila Ann Sprague

Jennifer Tsang

David Williamson

Diane Heels-Ansdell

Karim Soliman

Ruxandra Pinto

John Muscedere

Kiran Rabheru

Maureen Meade

Lauralyn McIntyre

Kwadwo Kyeremanteng

Stephanie Sibley

Ayub Akbari

Ryan Zarychanski

Bram Rochwerg

Wael Shabana

Bram Rochwerg

Mathilde Gaudreau-Simard

Patrick Archambault

Kelly Vogt

Husein Moloo

Martine Lebrasseur

Kirsten Fiest

Authors reply: "What every intensivist should know about…Methylene blue in septic shock".